Cold-chain freight: difference between revisions
Diff·revision 10 → 11·23:58, 17 Mar 2025
Difference between revision 10 and revision 11 of Cold-chain freight. 3 lines changed; the page grew by 474 bytes.
| Revision 10 — 19:44, 3 Mar 2025 ResinRhoswen (talk) expand §Monitoring 3,225 bytes +114 | Revision 11 — 23:58, 17 Mar 2025 TesamorelinTeg (talk) add the collapse-temperature point, sourced 3,699 bytes +474 | ||
|---|---|---|---|
| 32 | A threshold indicator that has not tripped establishes that a specific threshold was not crossed, which is genuinely informative and is much less than a profile. A logger record is the strongest evidence available and is uncommon outside pharmaceutical distribution.{{r|usp1079}} | 32 | A threshold indicator that has not tripped establishes that a specific threshold was not crossed, which is genuinely informative and is much less than a profile. A logger record is the strongest evidence available and is uncommon outside pharmaceutical distribution.{{r|usp1079}} |
| 33 | 33 | ||
| + | 34 | Reports submitted to this wiki that mention temperature control most often mention the state of the coolant on arrival. That is a weak observation: a pack can be solid on arrival after a period at ambient if it was frozen at dispatch, and can be liquid on arrival without the contents having exceeded the intended range.{{r|reports}} | |
| + | 35 | ||
| 34 | == References == | 36 | == References == |
| 35 | {{reflist}} | 37 | {{reflist}} |
| 36 | <ref name="ich_q1a">International Council for Harmonisation, ''Q1A(R2): Stability Testing of New Drug Substances and Products'' (2003).</ref> | 38 | <ref name="ich_q1a">International Council for Harmonisation, ''Q1A(R2): Stability Testing of New Drug Substances and Products'' (2003).</ref> |
| 37 | <ref name="usp1079">United States Pharmacopeia, General Chapter <1079>, ''Risks and Mitigation Strategies for the Storage and Transportation of Finished Drug Products''.</ref> | 39 | <ref name="usp1079">United States Pharmacopeia, General Chapter <1079>, ''Risks and Mitigation Strategies for the Storage and Transportation of Finished Drug Products''.</ref> |
| + | 40 | <ref name="reports">PeptidePedia Wiki community test-report tally, 2024–2026 (self-reported; see [[Project:Sourcing_guidelines]]).</ref> | |
| 38 | 41 | ||
| 39 | == See also == | 42 | == See also == |